Humacyte Inc.

NASDAQ: HUMA
Share price (12/20/24): $4.64
Market cap (12/20/24): $584 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Prospectus supplement

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Niklason Laura E

Prichard Heather Ledbetter

Constantino Michael T.

News Filter

Announces FDA Approval of SYMVESS™ (Acellular Tissue Engineered Vessel-Tyod) for the Treatment of Extremity Vascular Trauma

Announces Pricing of $15.0 Million Registered Direct Offering

Third Quarter 2024 Financial Results and Business Update

Announces Presentation of Positive Results From V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024

Announces Pricing of $30.0 Million Registered Direct Offering

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC